Parsortix PC1 Device
May 2022
603d
Angle Europe , Ltd.
1
Total
0
Cleared
1
Denied
Angle Europe , Ltd. — FDA 510(k) Submissions
Angle Europe , Ltd. has submitted 1 FDA 510(k) premarket notifications since 2022, of which 0 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Circulating Tumor Cell (ctc) Enrichment Device . Use the specialty filter in the sidebar to narrow results.
1 devices